Global Anti-Radiation Drugs Market Value to Reach US$ 2.34 Billion by 2034, Driven by a 7.5% CAGR (2026–2034)
The Anti-Radiation Drugs Market is expanding as governments, defense agencies, oncology centers, and pharmaceutical developers prioritize medical countermeasures that mitigate cellular damage from ionizing radiation. Growth is supported by rising cancer radiotherapy volumes, heightened geopolitical and nuclear safety preparedness, national emergency stockpiling programs, and advancements in...
0 Commentaires
0 Parts
46 Vue